KRMD KORU MEDICAL SYSTEMS INC revenue, earnings and financials

For the quarter ended June 30, 2026, KORU MEDICAL SYSTEMS INC reported revenue of $12.0M (up 18.2% from a year earlier), net income of $252K and diluted EPS of $0.01; over the last four quarters revenue was $45.1M and net income −$1.82M; for the fiscal year ended December 2025 revenue was $41.1M, up 22.2% on the year before.

KRMD annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $41.1M, gross profit $25.6M, operating income −$2.97M, net income −$2.64M (margin -6.4%), EPS −$0.06
• Fiscal year ended Dec 2024: revenue $33.6M, gross profit $21.3M, operating income −$6.45M, net income −$6.07M (margin -18.0%), EPS −$0.13
• Fiscal year ended Dec 2023: revenue $28.5M, gross profit $16.7M, operating income −$10.3M, net income −$13.7M (margin -48.2%), EPS −$0.30
• Fiscal year ended Dec 2022: revenue $27.9M, gross profit $15.4M, operating income −$10.8M, net income −$8.66M (margin -31.0%), EPS −$0.19
• Fiscal year ended Dec 2021: revenue $23.5M, gross profit $13.8M, operating income −$7.03M, net income −$4.56M (margin -19.4%), EPS −$0.10

KRMD quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $12.0M (up 18.2% year over year), net income $252K, EPS $0.01
• Quarter ended Mar 31, 2026: revenue $11.8M (up 22.1% year over year), net income −$807K, EPS −$0.02
• Quarter ended Dec 31, 2025 (from the annual report): revenue $10.9M (up 23.3% year over year), net income −$487K, EPS −$0.05
• Quarter ended Sep 30, 2025: revenue $10.4M (up 27.2% year over year), net income −$778K, EPS $0.02
• Quarter ended Jun 30, 2025: revenue $10.2M (up 20.9% year over year), net income −$207K, EPS $0.00
• Quarter ended Mar 31, 2025: revenue $9.64M (up 17.5% year over year), net income −$1.17M, EPS −$0.03
• Quarter ended Dec 31, 2024 (from the annual report): revenue $8.84M (up 23.0% year over year), net income −$1.56M, EPS −$0.22
• Quarter ended Sep 30, 2024: revenue $8.18M (up 16.8% year over year), net income −$1.58M, EPS $0.03
• Quarter ended Jun 30, 2024: revenue $8.43M (up 21.5% year over year), net income −$989K, EPS $0.02
• Quarter ended Mar 31, 2024: revenue $8.20M (up 10.9% year over year), net income −$1.94M, EPS $0.04
• Quarter ended Dec 31, 2023 (from the annual report): revenue $7.19M (down 2.2% year over year), net income −$7.47M, EPS −$0.17
• Quarter ended Sep 30, 2023: revenue $7.00M (down 9.8% year over year), net income −$1.37M, EPS −$0.03
• Quarter ended Jun 30, 2023: revenue $6.94M (up 5.9% year over year), net income −$2.50M, EPS −$0.05
• Quarter ended Mar 31, 2023: revenue $7.39M (up 18.4% year over year), net income −$2.41M, EPS −$0.05
• Quarter ended Dec 31, 2022 (from the annual report): revenue $7.34M (up 13.2% year over year), net income −$1.98M, EPS −$0.03
• Quarter ended Sep 30, 2022: revenue $7.76M (up 28.5% year over year), net income −$1.23M, EPS −$0.03
• Quarter ended Jun 30, 2022: revenue $6.55M (up 18.4% year over year), net income −$2.92M, EPS −$0.07
• Quarter ended Mar 31, 2022: revenue $6.24M (up 15.0% year over year), net income −$2.54M, EPS −$0.06
• Quarter ended Dec 31, 2021 (from the annual report): revenue $6.49M, net income −$1.07M, EPS −$0.02
• Quarter ended Sep 30, 2021: revenue $6.04M, net income −$1.09M, EPS −$0.02

KRMD cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $462K, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$320K, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$4.89M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$5.40M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$4.32M, share buybacks n/a

KRMD balance sheet

• Jun 30, 2026: cash $8.29M, total assets $28.0M, total liabilities $9.91M, shareholders' equity $18.1M
• Mar 31, 2026: cash $8.77M, total assets $28.6M, total liabilities $11.7M, shareholders' equity $16.9M
• Dec 31, 2025: cash $8.87M, total assets $28.2M, total liabilities $11.2M, shareholders' equity $17.0M
• Sep 30, 2025: cash $8.46M, total assets $27.1M, total liabilities $10.6M, shareholders' equity $16.5M
• Jun 30, 2025: cash $8.05M, total assets $25.5M, total liabilities $8.99M, shareholders' equity $16.5M
• Mar 31, 2025: cash $8.74M, total assets $27.2M, total liabilities $10.9M, shareholders' equity $16.3M
• Dec 31, 2024: cash $9.58M, total assets $27.2M, total liabilities $10.4M, shareholders' equity $16.8M
• Sep 30, 2024: cash $8.81M, total assets $27.4M, total liabilities $9.66M, shareholders' equity $17.7M

What is KRMD's revenue?

KORU MEDICAL SYSTEMS INC reported $45.1M of revenue over its last four quarters, through June 30, 2026.

Is KRMD profitable?

No. KORU MEDICAL SYSTEMS INC lost $1.82M over the last four quarters.

What is KRMD's EPS?

Diluted earnings per share over the last four quarters were −$0.04; $0.01 in the latest quarter.

KRMD ownership and insider trades · All stocks